Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alpine Immune Sciences Inc | 3,813,926 | 2,253,183 | -1,560,743 | $72.69M | $89.32M | 23.00% | +$16.62M |
| Merus N V | 1,135,225 | 1,509,007 | +373,782 | $31.22M | $67.95M | 17.50% | +$36.73M |
| Stoke Therapeutics, Inc.(STOK) | 2,956,918 | 3,696,820 | +739,902 | $15.55M | $49.91M | 12.85% | +$34.35M |
| TScan Therapeutics, Inc.(TCRX) | 5,224,600 | 5,224,600 | 0 | $30.46M | $41.48M | 10.68% | +$11.02M |
| Cabaletta Bio, Inc.(CABA) | 2,110,401 | 2,082,973 | -27,428 | $47.91M | $35.54M | 9.15% | -$12.37M |
| GH Research PLC(GHRS) | 1,838,617 | 3,310,563 | +1,471,946 | $10.66M | $35.29M | 9.09% | +$24.63M |
| C4 Therapeutics, Inc.(CCCC) | 3,134,396 | 3,634,662 | +500,266 | $17.71M | $29.70M | 7.65% | +$11.99M |
| Silence Therapeutics plcADS(SLN) | 235,787 | 526,642 | +290,855 | $4.10M | $11.38M | 2.93% | +$7.28M |
| Autolus Therapeutics plcADS(AUTL) | 1,858,409 | 1,390,160 | -468,249 | $11.97M | $8.87M | 2.28% | -$3.10M |
| Passage Bio, Inc.(PASG) | 379,159 | 4,845,871 | +4,466,712 | $383.0K | $6.54M | 1.68% | +$6.16M |
| Kinnate Biopharma Inc | 1,997,006 | 1,981,106 | -15,900 | $4.73M | $5.27M | 1.36% | +$536.8K |
| iBio, Inc.CON NEW(IBIO) | 0 | 600,000 | +600,000 | $0 | $2.44M | 0.63% | +$2.44M |
| Nektar Therapeutics(NKTR) | 1,929,198 | 2,068,842 | +139,644 | $1.09M | $1.93M | 0.50% | +$842.7K |
| Pieris Pharmaceuticals Inc | 9,775,849 | 8,779,162 | -996,687 | $1.78M | $1.61M | 0.41% | -$170.9K |
| Bionomics LimitedADS | 824,305 | 814,467 | -9,838 | $1.22M | $838.9K | 0.22% | -$381.1K |
| Centessa Pharmaceuticals PlcADS | 0 | 17,400 | +17,400 | $0 | $196.6K | 0.05% | +$196.6K |
| Theseus Pharmaceuticals Inc | 702,415 | 0 | -702,415 | $2.84M | $0 | — | -$2.84M |